TrialJournal of diabetes investigation2018

Fast-acting insulin aspart in Japanese patients with type 1 diabetes: Faster onset, higher early exposure and greater early glucose-lowering effect relative to insulin aspart.

Masanari Shiramoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.